Table of Content

1 Report Overview
1.1 Glycogen Synthase Kinase 3 Beta Definition
1.2 Market by Type
1.2.1 Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 AP-001
1.2.3 AP-1
1.2.4 DM-204
1.2.5 Neu-120
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Musculoskeletal Disorder
1.3.3 Lung Cancer
1.3.4 Dyskinesia
1.3.5 Menkes Disease
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Glycogen Synthase Kinase 3 Beta Sales
2.1 Global Glycogen Synthase Kinase 3 Beta Revenue Estimates and Forecasts 2018-2034
2.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Glycogen Synthase Kinase 3 Beta Revenue by Region
2.3.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2018-2023)
2.3.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2024-2034)
2.4 Global Glycogen Synthase Kinase 3 Beta Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Region
2.6.1 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Region (2018-2023)
2.6.2 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Manufacturers
3.1.1 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Glycogen Synthase Kinase 3 Beta Sales in 2024
3.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers
3.2.1 Global Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers (2018-2023)
3.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Glycogen Synthase Kinase 3 Beta Revenue in 2024
3.3 Global Glycogen Synthase Kinase 3 Beta Sales Price by Manufacturers
3.4 Global Key Players of Glycogen Synthase Kinase 3 Beta, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Glycogen Synthase Kinase 3 Beta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Glycogen Synthase Kinase 3 Beta, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Glycogen Synthase Kinase 3 Beta, Product Offered and Application
3.8 Global Key Manufacturers of Glycogen Synthase Kinase 3 Beta, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Type
4.1.1 Global Glycogen Synthase Kinase 3 Beta Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Glycogen Synthase Kinase 3 Beta Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Type (2018-2034)
4.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Type
4.2.1 Global Glycogen Synthase Kinase 3 Beta Historical Revenue by Type (2018-2023)
4.2.2 Global Glycogen Synthase Kinase 3 Beta Forecasted Revenue by Type (2024-2034)
4.2.3 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2018-2034)
4.3 Global Glycogen Synthase Kinase 3 Beta Price by Type
4.3.1 Global Glycogen Synthase Kinase 3 Beta Price by Type (2018-2023)
4.3.2 Global Glycogen Synthase Kinase 3 Beta Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Application
5.1.1 Global Glycogen Synthase Kinase 3 Beta Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Glycogen Synthase Kinase 3 Beta Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Application (2018-2034)
5.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Application
5.2.1 Global Glycogen Synthase Kinase 3 Beta Historical Revenue by Application (2018-2023)
5.2.2 Global Glycogen Synthase Kinase 3 Beta Forecasted Revenue by Application (2024-2034)
5.2.3 Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2018-2034)
5.3 Global Glycogen Synthase Kinase 3 Beta Price by Application
5.3.1 Global Glycogen Synthase Kinase 3 Beta Price by Application (2018-2023)
5.3.2 Global Glycogen Synthase Kinase 3 Beta Price Forecast by Application (2024-2034)
6 North America
6.1 North America Glycogen Synthase Kinase 3 Beta Sales by Company
6.1.1 North America Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023)
6.1.2 North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023)
6.2 North America Glycogen Synthase Kinase 3 Beta Market Size by Type
6.2.1 North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2034)
6.2.2 North America Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2034)
6.3 North America Glycogen Synthase Kinase 3 Beta Market Size by Application
6.3.1 North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2034)
6.3.2 North America Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2034)
6.4 North America Glycogen Synthase Kinase 3 Beta Market Size by Country
6.4.1 North America Glycogen Synthase Kinase 3 Beta Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Glycogen Synthase Kinase 3 Beta Revenue by Country (2018-2034)
6.4.3 North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Glycogen Synthase Kinase 3 Beta Sales by Company
7.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023)
7.1.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023)
7.2 Europe Glycogen Synthase Kinase 3 Beta Market Size by Type
7.2.1 Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2034)
7.2.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2034)
7.3 Europe Glycogen Synthase Kinase 3 Beta Market Size by Application
7.3.1 Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2034)
7.3.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2034)
7.4 Europe Glycogen Synthase Kinase 3 Beta Market Size by Country
7.4.1 Europe Glycogen Synthase Kinase 3 Beta Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2018-2034)
7.4.3 Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Glycogen Synthase Kinase 3 Beta Sales by Company
8.1.1 China Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023)
8.1.2 China Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023)
8.2 China Glycogen Synthase Kinase 3 Beta Market Size by Type
8.2.1 China Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2034)
8.2.2 China Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2034)
8.3 China Glycogen Synthase Kinase 3 Beta Market Size by Application
8.3.1 China Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2034)
8.3.2 China Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Glycogen Synthase Kinase 3 Beta Sales by Company
9.1.1 APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023)
9.1.2 APAC Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023)
9.2 APAC Glycogen Synthase Kinase 3 Beta Market Size by Type
9.2.1 APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2034)
9.2.2 APAC Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2034)
9.3 APAC Glycogen Synthase Kinase 3 Beta Market Size by Application
9.3.1 APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2034)
9.3.2 APAC Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2034)
9.4 APAC Glycogen Synthase Kinase 3 Beta Market Size by Region
9.4.1 APAC Glycogen Synthase Kinase 3 Beta Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2018-2034)
9.4.3 APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales by Company
10.1.1 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Market Size by Type
10.2.1 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Market Size by Application
10.3.1 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Market Size by Country
10.4.1 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Mitsubishi Tanabe Pharma Corp
11.1.1 Mitsubishi Tanabe Pharma Corp Company Information
11.1.2 Mitsubishi Tanabe Pharma Corp Overview
11.1.3 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Products and Services
11.1.5 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta SWOT Analysis
11.1.6 Mitsubishi Tanabe Pharma Corp Recent Developments
11.2 Neurim Pharmaceuticals Ltd
11.2.1 Neurim Pharmaceuticals Ltd Company Information
11.2.2 Neurim Pharmaceuticals Ltd Overview
11.2.3 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Products and Services
11.2.5 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta SWOT Analysis
11.2.6 Neurim Pharmaceuticals Ltd Recent Developments
11.3 Actuate Therapeutics Inc
11.3.1 Actuate Therapeutics Inc Company Information
11.3.2 Actuate Therapeutics Inc Overview
11.3.3 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Products and Services
11.3.5 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta SWOT Analysis
11.3.6 Actuate Therapeutics Inc Recent Developments
11.4 DiaMedica Therapeutics Inc
11.4.1 DiaMedica Therapeutics Inc Company Information
11.4.2 DiaMedica Therapeutics Inc Overview
11.4.3 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Products and Services
11.4.5 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta SWOT Analysis
11.4.6 DiaMedica Therapeutics Inc Recent Developments
11.5 Angelini Group
11.5.1 Angelini Group Company Information
11.5.2 Angelini Group Overview
11.5.3 Angelini Group Glycogen Synthase Kinase 3 Beta Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Angelini Group Glycogen Synthase Kinase 3 Beta Products and Services
11.5.5 Angelini Group Glycogen Synthase Kinase 3 Beta SWOT Analysis
11.5.6 Angelini Group Recent Developments
11.6 Jeil Pharmaceutical Co Ltd
11.6.1 Jeil Pharmaceutical Co Ltd Company Information
11.6.2 Jeil Pharmaceutical Co Ltd Overview
11.6.3 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Products and Services
11.6.5 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta SWOT Analysis
11.6.6 Jeil Pharmaceutical Co Ltd Recent Developments
11.7 AMO Pharma Ltd
11.7.1 AMO Pharma Ltd Company Information
11.7.2 AMO Pharma Ltd Overview
11.7.3 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Products and Services
11.7.5 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta SWOT Analysis
11.7.6 AMO Pharma Ltd Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Glycogen Synthase Kinase 3 Beta Value Chain Analysis
12.2 Glycogen Synthase Kinase 3 Beta Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Glycogen Synthase Kinase 3 Beta Production Mode & Process
12.4 Glycogen Synthase Kinase 3 Beta Sales and Marketing
12.4.1 Glycogen Synthase Kinase 3 Beta Sales Channels
12.4.2 Glycogen Synthase Kinase 3 Beta Distributors
12.5 Glycogen Synthase Kinase 3 Beta Customers
13 Market Dynamics
13.1 Glycogen Synthase Kinase 3 Beta Industry Trends
13.2 Glycogen Synthase Kinase 3 Beta Market Drivers
13.3 Glycogen Synthase Kinase 3 Beta Market Challenges
13.4 Glycogen Synthase Kinase 3 Beta Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of AP-001
Table 3. Major Manufacturers of AP-1
Table 4. Major Manufacturers of DM-204
Table 5. Major Manufacturers of Neu-120
Table 6. Major Manufacturers of Others
Table 7. Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Glycogen Synthase Kinase 3 Beta Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2018-2023)
Table 11. Global Glycogen Synthase Kinase 3 Beta Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2024-2034)
Table 13. Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Glycogen Synthase Kinase 3 Beta Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2018-2023)
Table 16. Global Glycogen Synthase Kinase 3 Beta Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2024-2034)
Table 18. Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Glycogen Synthase Kinase 3 Beta Revenue Share by Manufacturers (2018-2023)
Table 22. Global Glycogen Synthase Kinase 3 Beta Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Glycogen Synthase Kinase 3 Beta, Industry Ranking, 2021 VS 2024
Table 24. Global Glycogen Synthase Kinase 3 Beta Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Glycogen Synthase Kinase 3 Beta by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycogen Synthase Kinase 3 Beta as of 2024)
Table 26. Global Key Manufacturers of Glycogen Synthase Kinase 3 Beta, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Glycogen Synthase Kinase 3 Beta, Product Offered and Application
Table 28. Global Key Manufacturers of Glycogen Synthase Kinase 3 Beta, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Type (2018-2023)
Table 33. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Type (2024-2034)
Table 34. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Glycogen Synthase Kinase 3 Beta Revenue Share by Type (2018-2023)
Table 37. Global Glycogen Synthase Kinase 3 Beta Revenue Share by Type (2024-2034)
Table 38. Glycogen Synthase Kinase 3 Beta Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Glycogen Synthase Kinase 3 Beta Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Application (2018-2023)
Table 43. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Application (2024-2034)
Table 44. Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Glycogen Synthase Kinase 3 Beta Revenue Share by Application (2018-2023)
Table 47. Global Glycogen Synthase Kinase 3 Beta Revenue Share by Application (2024-2034)
Table 48. Glycogen Synthase Kinase 3 Beta Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Glycogen Synthase Kinase 3 Beta Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Glycogen Synthase Kinase 3 Beta Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Glycogen Synthase Kinase 3 Beta Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Glycogen Synthase Kinase 3 Beta Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Glycogen Synthase Kinase 3 Beta Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Glycogen Synthase Kinase 3 Beta Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Glycogen Synthase Kinase 3 Beta Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Glycogen Synthase Kinase 3 Beta Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Glycogen Synthase Kinase 3 Beta Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Glycogen Synthase Kinase 3 Beta Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Glycogen Synthase Kinase 3 Beta Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Glycogen Synthase Kinase 3 Beta Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Glycogen Synthase Kinase 3 Beta Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Glycogen Synthase Kinase 3 Beta Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Glycogen Synthase Kinase 3 Beta Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Mitsubishi Tanabe Pharma Corp Company Information
Table 121. Mitsubishi Tanabe Pharma Corp Description and Overview
Table 122. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Product and Services
Table 124. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta SWOT Analysis
Table 125. Mitsubishi Tanabe Pharma Corp Recent Developments
Table 126. Neurim Pharmaceuticals Ltd Company Information
Table 127. Neurim Pharmaceuticals Ltd Description and Overview
Table 128. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Product and Services
Table 130. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta SWOT Analysis
Table 131. Neurim Pharmaceuticals Ltd Recent Developments
Table 132. Actuate Therapeutics Inc Company Information
Table 133. Actuate Therapeutics Inc Description and Overview
Table 134. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product and Services
Table 136. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta SWOT Analysis
Table 137. Actuate Therapeutics Inc Recent Developments
Table 138. DiaMedica Therapeutics Inc Company Information
Table 139. DiaMedica Therapeutics Inc Description and Overview
Table 140. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Product and Services
Table 142. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta SWOT Analysis
Table 143. DiaMedica Therapeutics Inc Recent Developments
Table 144. Angelini Group Company Information
Table 145. Angelini Group Description and Overview
Table 146. Angelini Group Glycogen Synthase Kinase 3 Beta Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 147. Angelini Group Glycogen Synthase Kinase 3 Beta Product and Services
Table 148. Angelini Group Glycogen Synthase Kinase 3 Beta SWOT Analysis
Table 149. Angelini Group Recent Developments
Table 150. Jeil Pharmaceutical Co Ltd Company Information
Table 151. Jeil Pharmaceutical Co Ltd Description and Overview
Table 152. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Product and Services
Table 154. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta SWOT Analysis
Table 155. Jeil Pharmaceutical Co Ltd Recent Developments
Table 156. AMO Pharma Ltd Company Information
Table 157. AMO Pharma Ltd Description and Overview
Table 158. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 159. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Product and Services
Table 160. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta SWOT Analysis
Table 161. AMO Pharma Ltd Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Glycogen Synthase Kinase 3 Beta Distributors List
Table 165. Glycogen Synthase Kinase 3 Beta Customers List
Table 166. Glycogen Synthase Kinase 3 Beta Market Trends
Table 167. Glycogen Synthase Kinase 3 Beta Market Drivers
Table 168. Glycogen Synthase Kinase 3 Beta Market Challenges
Table 169. Glycogen Synthase Kinase 3 Beta Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Glycogen Synthase Kinase 3 Beta Product Picture
Figure 2. Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Glycogen Synthase Kinase 3 Beta Market Share by Type in 2024 & 2034
Figure 4. AP-001 Product Picture
Figure 5. AP-1 Product Picture
Figure 6. DM-204 Product Picture
Figure 7. Neu-120 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Glycogen Synthase Kinase 3 Beta Market Share by Application in 2024 & 2034
Figure 11. Musculoskeletal Disorder
Figure 12. Lung Cancer
Figure 13. Dyskinesia
Figure 14. Menkes Disease
Figure 15. Others
Figure 16. Glycogen Synthase Kinase 3 Beta Report Years Considered
Figure 17. Global Glycogen Synthase Kinase 3 Beta Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Glycogen Synthase Kinase 3 Beta Revenue 2018-2034 (US$ Million)
Figure 19. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 20. Global Glycogen Synthase Kinase 3 Beta Sales Quantity 2018-2034 (K Pcs)
Figure 21. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Region (2018-2023)
Figure 22. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Region (2024-2034)
Figure 23. North America Glycogen Synthase Kinase 3 Beta Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. North America Glycogen Synthase Kinase 3 Beta Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. Europe Glycogen Synthase Kinase 3 Beta Revenue YoY (2018-2034) & (US$ Million)
Figure 27. China Glycogen Synthase Kinase 3 Beta Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. China Glycogen Synthase Kinase 3 Beta Revenue YoY (2018-2034) & (US$ Million)
Figure 29. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. APAC Glycogen Synthase Kinase 3 Beta Revenue YoY (2018-2034) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 32. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue YoY (2018-2034) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Glycogen Synthase Kinase 3 Beta Sales Quantity in 2024
Figure 34. The Top 10 and Top 5 Players Market Share by Glycogen Synthase Kinase 3 Beta Revenue in 2024
Figure 35. Glycogen Synthase Kinase 3 Beta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 36. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Type (2018-2034)
Figure 37. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2018-2034)
Figure 38. Global Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Application (2018-2034)
Figure 39. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2018-2034)
Figure 40. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company in 2024
Figure 41. North America Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Company in 2024
Figure 42. North America Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Type (2018-2034)
Figure 43. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2018-2034)
Figure 44. North America Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Application (2018-2034)
Figure 45. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2018-2034)
Figure 46. North America Glycogen Synthase Kinase 3 Beta Revenue Share by Country (2018-2034)
Figure 47. North America Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Country (2018-2034)
Figure 48. U.S. Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 49. Canada Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 50. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Company in 2024
Figure 51. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company in 2024
Figure 52. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Type (2018-2034)
Figure 53. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2018-2034)
Figure 54. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Application (2018-2034)
Figure 55. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2018-2034)
Figure 56. Europe Glycogen Synthase Kinase 3 Beta Revenue Share by Country (2018-2034)
Figure 57. Europe Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Country (2018-2034)
Figure 58. Germany Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 59. France Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 60. U.K. Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 61. Italy Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 62. Russia Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 63. China Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Company in 2024
Figure 64. China Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company in 2024
Figure 65. China Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Type (2018-2034)
Figure 66. China Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2018-2034)
Figure 67. China Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Application (2018-2034)
Figure 68. China Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2018-2034)
Figure 69. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Company in 2024
Figure 70. APAC Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company in 2024
Figure 71. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Type (2018-2034)
Figure 72. APAC Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2018-2034)
Figure 73. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Application (2018-2034)
Figure 74. APAC Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2018-2034)
Figure 75. APAC Glycogen Synthase Kinase 3 Beta Revenue Share by Region (2018-2034)
Figure 76. APAC Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Region (2018-2034)
Figure 77. Japan Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 78. South Korea Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 79. China Taiwan Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 80. Southeast Asia Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 81. India Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 82. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Company in 2024
Figure 83. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Type (2018-2034)
Figure 85. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity Market Share by Application (2018-2034)
Figure 87. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Sales Quantity Share by Country (2018-2034)
Figure 89. Middle East, Africa and Latin America Glycogen Synthase Kinase 3 Beta Revenue Share by Country (2018-2034)
Figure 90. Brazil Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 91. Mexico Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 92. Turkey Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 93. Israel Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 94. GCC Countries Glycogen Synthase Kinase 3 Beta Revenue (2018-2034) & (US$ Million)
Figure 95. Glycogen Synthase Kinase 3 Beta Value Chain
Figure 96. Glycogen Synthase Kinase 3 Beta Production Process
Figure 97. Channels of Distribution (Direct Vs Distribution)
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed